Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mind Medicine (MindMed) Inc N.MMED.WR


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED

Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

Recent & Breaking News (NDAQ:MNMD)

New Discovery Increases Understanding of Broadway’s Porphyry System

GlobeNewswire June 14, 2018

Broadway Gold Mining Announces Re-pricing of Options

GlobeNewswire June 8, 2018

Update on Strategic Direction of Broadway Gold Mining Ltd.

GlobeNewswire May 30, 2018

Broadway Announces New President and CEO

GlobeNewswire May 4, 2018

Broadway Update on Madison Copper-Gold Porphyry Discovery, Phase III Drilling

GlobeNewswire March 6, 2018

Broadway Provides Update on Madison Copper-Gold Porphyry Discovery

MarketWire Canada January 22, 2018

Broadway Increases Madison Copper-Gold Land Holdings

MarketWire Canada November 7, 2017

Broadway Discovers Porphyry System at Madison

MarketWire Canada October 26, 2017

Montana Mining and Mineral Symposium Attendees to Tour Broadway's Madison Copper-Gold Project

MarketWire Canada October 11, 2017

Broadway Targets Copper-Gold Porphyry, Commences Phase III Drill Program

MarketWire Canada September 18, 2017

Broadway Adds Senior Geologist to Team

MarketWire Canada September 12, 2017

Broadway Identifies Copper-Gold Porphyry Targets, Plans Phase III Drilling Based on New Geological Model

MarketWire Canada September 7, 2017

Broadway Confirms Down Dip Extension of Massive Sulfide, Intersects 23.8 Meters of 1.247% Copper and 1.843 g/t Gold

MarketWire Canada July 19, 2017

Broadway Appoints Two New Independent Directors

MarketWire Canada July 13, 2017

Broadway Drills Best Copper Hole to Date and Extends Copper Zone at Madison

MarketWire Canada July 11, 2017

Broadway Intercepts Additional Massive Sulfide Zone at Madison

MarketWire Canada June 28, 2017

Broadway Reports Continued Underground Drill Success at Madison: 1.098% Copper and 1.651 g/t Gold Over 25.3 Meters

MarketWire Canada June 15, 2017

Broadway Discovers New Gold Zone at Madison and Expands Native Copper Zone

MarketWire Canada May 18, 2017

Broadway Reports Continued Drill Success at Madison Underground: 41.6 g/t Gold Over 11 Meters

MarketWire Canada May 10, 2017

IIROC Trading Resumption - BRD

Canada NewsWire May 3, 2017